Pierre Fumoleau


Ontology type: schema:Person     


Person Info

NAME

Pierre

SURNAME

Fumoleau

Publications in SciGraph latest 50 shown

  • 2018-12 The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial) in BMC CANCER
  • 2017-12 Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort in NPJ BREAST CANCER
  • 2017-12 Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes in BREAST CANCER RESEARCH
  • 2017-01 Predictive factors of pathologic complete response of HER2-positive breast cancer after preoperative chemotherapy with trastuzumab: development of a specific predictor and study of its utilities using decision curve analysis in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-12 A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study in ONCOLOGY AND THERAPY
  • 2016-07-13 A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers in NATURE COMMUNICATIONS
  • 2015-12 Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy in BREAST CANCER RESEARCH
  • 2015-12 Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy in BMC CANCER
  • 2015-05 Pertuzumab et T-DM1 : de nouvelles perspectives dans le traitement du cancer du sein HER2 positif in ONCOLOGIE
  • 2014-08 Development of primary early-onset colorectal cancers due to biallelic mutations of the FANCD1/BRCA2 gene in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2014-08 HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2014-03 18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2014-03 Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancer in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2014 Imagerie moléculaire in LES BIOMARQUEURS MOLÉCULAIRES EN ONCOLOGIE
  • 2013-12 Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors in BMC CANCER
  • 2013-12 Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours in BMC CANCER
  • 2013-06 Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunction in INVESTIGATIONAL NEW DRUGS
  • 2013-03 New Vinca Alkaloids in Clinical Development in CURRENT BREAST CANCER REPORTS
  • 2012-08 Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours in BRITISH JOURNAL OF CANCER
  • 2012-04 A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2012-02 Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2 in BRITISH JOURNAL OF CANCER
  • 2012 Anti-HER2 et cancers du sein métastatiques: Résultats cliniques des anti-HER2 actuels et futurs in CANCER DU SEIN
  • 2012 Place des biomarqueurs dans la prise en charge du cancer du sein in CANCER DU SEIN
  • 2011-12 Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2011-11 High rate of extra-haematological toxicity compromises dose-dense sequential adjuvant chemotherapy for breast cancer in BRITISH JOURNAL OF CANCER
  • 2011-07 T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival in BRITISH JOURNAL OF CANCER
  • 2011-05 Trastuzumab et lapatinib dans la prise en charge du cancer du sein HER2 positif in JOURNAL AFRICAIN DU CANCER / AFRICAN JOURNAL OF CANCER
  • 2011-01 Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy in BREAST CANCER RESEARCH AND TREATMENT
  • 2010-10 Pathological complete response and survival according to the level of HER-2 amplification after trastuzumab-based neoadjuvant therapy for breast cancer in BRITISH JOURNAL OF CANCER
  • 2010-02 Rapport 2009 sur l’état des connaissances relatives aux biomarqueurs tissulaires uPA/PAI-1, Oncotype DX™ et MammaPrint® dans la prise en charge du cancer du sein in ONCOLOGIE
  • 2010 Stratégies thérapeutiques des cancers métastatiques RH+, HER2+ : trastuzumab, chimiothérapie, hormonothérapie in CANCER DU SEIN EN SITUATION MÉTASTATIQUE
  • 2009-10 Gene expression profile and response to trastuzumab–docetaxel-based treatment in breast carcinoma in BRITISH JOURNAL OF CANCER
  • 2008-10 Chimiothérapie et qualité de vie dans le cancer du sein métastatique: état des lieux in ONCOLOGIE
  • 2007-12 [18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2007-08 Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007-06 Epirubicin–vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial in BRITISH JOURNAL OF CANCER
  • 2007-04 Phase I dose-escalation study of a novel antitumor agent, SR271425, administered intravenously in split doses (d1–d2–d3) in patients with refractory solid tumors in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2007 Traitements néo-adjuvants des cancers du sein HER2 positif in CANCER DU SEIN
  • 2007 Autres traitements ciblés (trastuzumab exclu) in CANCER DU SEIN
  • 2006-11 Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy in BRITISH JOURNAL OF CANCER
  • 2006-05 Phase I study of Vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks in INVESTIGATIONAL NEW DRUGS
  • 2006 Les nouvelles cibles thérapeutiques. Les nouvelles thérapeutiques ciblées in CANCER DU SEIN
  • 2005-07 Identification of molecular apocrine breast tumours by microarray analysis in ONCOGENE
  • 2005-06 Identification of molecular apocrine breast tumours by microarray analysis in BREAST CANCER RESEARCH
  • 2005-06 Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam in INVESTIGATIONAL NEW DRUGS
  • 2004-11 Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program in BREAST CANCER RESEARCH AND TREATMENT
  • 2004-08 Phase II study on 9-nitrocamptothecin (RFS 2000) in patients with advanced or metastatic urothelial tract tumors in INVESTIGATIONAL NEW DRUGS
  • 2004-03 Traitement adjuvant du cancer du sein, aujourd’hui et demain: « Carte » ou « Menu »? in ONCOLOGIE
  • 2004-03 Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2004-01 G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis in BRITISH JOURNAL OF CANCER
  • Affiliations

  • Centre Georges François Leclerc (current)
  • Princess Grace Hospital Centre
  • Queen's University
  • Centre Hospitalier Lyon Sud
  • University of Burgundy
  • Imperial College London
  • Policlinico di Modena
  • Institut de Cancérologie de l'Ouest
  • University of Southern California
  • Hôpital Universitaire Dupuytren
  • Institut Bergonié
  • Institut Claudius Regaud
  • Hospital Universitario Miguel Servet
  • Centre Jean Perrin
  • University of Brescia
  • Dana–Farber Cancer Institute
  • University of Newcastle Australia
  • University of Lausanne
  • Beatson West of Scotland Cancer Centre
  • Universitaire Ziekenhuizen Leuven
  • Laurentius Ziekenhuis
  • Royal Free Hospital
  • University of Tübingen
  • Pfizer (France)
  • Centre Eugène Marquis
  • Hôtel-Dieu de Paris
  • The University of Texas MD Anderson Cancer Center
  • Institute Curie
  • Hospital Universitari Vall d'Hebron
  • Hospital Clínico Universitario de Valencia
  • St. Vincent's University Hospital
  • Nottingham City Hospital
  • Universitätsklinikum Tübingen
  • University of Alberta
  • Oregon Health & Science University
  • International Drug Development Institute (Belgium)
  • Karolinska University Hospital
  • Hospital Clínico Universitario Lozano Blesa
  • Ottawa Regional Cancer Foundation
  • Centre Hospitalier de Bretagne Sud
  • Fundación Instituto Valenciano de Oncología
  • Uppsala University Hospital
  • Centre Oscar Lambret
  • UniCancer Group
  • BC Cancer Agency
  • Eisai (United Kingdom)
  • Centre Franois Baclesse
  • University of Hasselt
  • Centre Léon Bérard
  • Sisters of Charity Hospital
  • Roche (United Kingdom)
  • Institut Sainte Catherine
  • Erasmus University Medical Center
  • Institut Gustave Roussy
  • University of California Los Angeles
  • Eli Lilly (Spain)
  • Memorial Sloan Kettering Cancer Center
  • Hospital Clínico San Carlos
  • Institut Jules Bordet
  • University of Basel
  • Institute Paoli-Calmettes
  • Heidelberg University
  • Beaujon Hospital
  • Kaiser-Franz-Josef-Spital
  • European Organisation for Research and Treatment of Cancer
  • Helios Dr. Horst Schmidt Kliniken Wiesbaden
  • Centre Antoine Lacassagne
  • Centennial Medical Center
  • Cliniques Universitaires Saint-Luc
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.418037.9", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.452334.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410356.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411430.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5613.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413363.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418191.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.42505.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412212.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.476460.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417829.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411106.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418113.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7637.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.266842.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9851.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.422301.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415842.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.426108.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10392.39", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.476471.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417988.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411394.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418596.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411083.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411308.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412751.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412920.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411544.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17089.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5288.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.482598.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.24381.3c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411050.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419945.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.477443.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418082.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412354.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.452351.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418189.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.248762.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.428696.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.476192.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.12155.32", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418116.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412488.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419227.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.482015.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.19006.3e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.476461.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411068.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418119.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.6612.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418443.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7700.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411599.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414836.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418936.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.491861.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417812.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413696.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48769.34", 
            "type": "Organization"
          }
        ], 
        "familyName": "Fumoleau", 
        "givenName": "Pierre", 
        "id": "sg:person.01101667531.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101667531.56"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:29", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_235.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01101667531.56'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01101667531.56'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01101667531.56'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01101667531.56'


     

    This table displays all metadata directly associated to this object as RDF triples.

    152 TRIPLES      10 PREDICATES      79 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01101667531.56 schema:affiliation N784c33ceed754471a38965e77721c2d7
    2 https://www.grid.ac/institutes/grid.10392.39
    3 https://www.grid.ac/institutes/grid.12155.32
    4 https://www.grid.ac/institutes/grid.14925.3b
    5 https://www.grid.ac/institutes/grid.17089.37
    6 https://www.grid.ac/institutes/grid.19006.3e
    7 https://www.grid.ac/institutes/grid.240145.6
    8 https://www.grid.ac/institutes/grid.24381.3c
    9 https://www.grid.ac/institutes/grid.248762.d
    10 https://www.grid.ac/institutes/grid.266842.c
    11 https://www.grid.ac/institutes/grid.410356.5
    12 https://www.grid.ac/institutes/grid.410569.f
    13 https://www.grid.ac/institutes/grid.411050.1
    14 https://www.grid.ac/institutes/grid.411068.a
    15 https://www.grid.ac/institutes/grid.411083.f
    16 https://www.grid.ac/institutes/grid.411106.3
    17 https://www.grid.ac/institutes/grid.411308.f
    18 https://www.grid.ac/institutes/grid.411394.a
    19 https://www.grid.ac/institutes/grid.411430.3
    20 https://www.grid.ac/institutes/grid.411544.1
    21 https://www.grid.ac/institutes/grid.411599.1
    22 https://www.grid.ac/institutes/grid.412212.6
    23 https://www.grid.ac/institutes/grid.412354.5
    24 https://www.grid.ac/institutes/grid.412488.3
    25 https://www.grid.ac/institutes/grid.412751.4
    26 https://www.grid.ac/institutes/grid.412920.c
    27 https://www.grid.ac/institutes/grid.413363.0
    28 https://www.grid.ac/institutes/grid.413696.f
    29 https://www.grid.ac/institutes/grid.414836.c
    30 https://www.grid.ac/institutes/grid.415842.e
    31 https://www.grid.ac/institutes/grid.417812.9
    32 https://www.grid.ac/institutes/grid.417829.1
    33 https://www.grid.ac/institutes/grid.417988.b
    34 https://www.grid.ac/institutes/grid.418082.7
    35 https://www.grid.ac/institutes/grid.418113.e
    36 https://www.grid.ac/institutes/grid.418116.b
    37 https://www.grid.ac/institutes/grid.418119.4
    38 https://www.grid.ac/institutes/grid.418189.d
    39 https://www.grid.ac/institutes/grid.418191.4
    40 https://www.grid.ac/institutes/grid.418443.e
    41 https://www.grid.ac/institutes/grid.418596.7
    42 https://www.grid.ac/institutes/grid.418936.1
    43 https://www.grid.ac/institutes/grid.419227.b
    44 https://www.grid.ac/institutes/grid.419945.4
    45 https://www.grid.ac/institutes/grid.422301.6
    46 https://www.grid.ac/institutes/grid.42505.36
    47 https://www.grid.ac/institutes/grid.426108.9
    48 https://www.grid.ac/institutes/grid.428696.7
    49 https://www.grid.ac/institutes/grid.452334.7
    50 https://www.grid.ac/institutes/grid.452351.4
    51 https://www.grid.ac/institutes/grid.476192.f
    52 https://www.grid.ac/institutes/grid.476460.7
    53 https://www.grid.ac/institutes/grid.476461.6
    54 https://www.grid.ac/institutes/grid.476471.7
    55 https://www.grid.ac/institutes/grid.477443.7
    56 https://www.grid.ac/institutes/grid.482015.a
    57 https://www.grid.ac/institutes/grid.482598.a
    58 https://www.grid.ac/institutes/grid.48769.34
    59 https://www.grid.ac/institutes/grid.491861.3
    60 https://www.grid.ac/institutes/grid.51462.34
    61 https://www.grid.ac/institutes/grid.5288.7
    62 https://www.grid.ac/institutes/grid.5613.1
    63 https://www.grid.ac/institutes/grid.5645.2
    64 https://www.grid.ac/institutes/grid.65499.37
    65 https://www.grid.ac/institutes/grid.6612.3
    66 https://www.grid.ac/institutes/grid.7445.2
    67 https://www.grid.ac/institutes/grid.7637.5
    68 https://www.grid.ac/institutes/grid.7700.0
    69 https://www.grid.ac/institutes/grid.9851.5
    70 schema:familyName Fumoleau
    71 schema:givenName Pierre
    72 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101667531.56
    73 schema:sdDatePublished 2019-03-07T14:29
    74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    75 schema:sdPublisher N48abd2103e1d4e71b72412b3e4ee98ab
    76 sgo:license sg:explorer/license/
    77 sgo:sdDataset persons
    78 rdf:type schema:Person
    79 N48abd2103e1d4e71b72412b3e4ee98ab schema:name Springer Nature - SN SciGraph project
    80 rdf:type schema:Organization
    81 N784c33ceed754471a38965e77721c2d7 schema:affiliation https://www.grid.ac/institutes/grid.418037.9
    82 sgo:isCurrent true
    83 rdf:type schema:OrganizationRole
    84 https://www.grid.ac/institutes/grid.10392.39 schema:Organization
    85 https://www.grid.ac/institutes/grid.12155.32 schema:Organization
    86 https://www.grid.ac/institutes/grid.14925.3b schema:Organization
    87 https://www.grid.ac/institutes/grid.17089.37 schema:Organization
    88 https://www.grid.ac/institutes/grid.19006.3e schema:Organization
    89 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    90 https://www.grid.ac/institutes/grid.24381.3c schema:Organization
    91 https://www.grid.ac/institutes/grid.248762.d schema:Organization
    92 https://www.grid.ac/institutes/grid.266842.c schema:Organization
    93 https://www.grid.ac/institutes/grid.410356.5 schema:Organization
    94 https://www.grid.ac/institutes/grid.410569.f schema:Organization
    95 https://www.grid.ac/institutes/grid.411050.1 schema:Organization
    96 https://www.grid.ac/institutes/grid.411068.a schema:Organization
    97 https://www.grid.ac/institutes/grid.411083.f schema:Organization
    98 https://www.grid.ac/institutes/grid.411106.3 schema:Organization
    99 https://www.grid.ac/institutes/grid.411308.f schema:Organization
    100 https://www.grid.ac/institutes/grid.411394.a schema:Organization
    101 https://www.grid.ac/institutes/grid.411430.3 schema:Organization
    102 https://www.grid.ac/institutes/grid.411544.1 schema:Organization
    103 https://www.grid.ac/institutes/grid.411599.1 schema:Organization
    104 https://www.grid.ac/institutes/grid.412212.6 schema:Organization
    105 https://www.grid.ac/institutes/grid.412354.5 schema:Organization
    106 https://www.grid.ac/institutes/grid.412488.3 schema:Organization
    107 https://www.grid.ac/institutes/grid.412751.4 schema:Organization
    108 https://www.grid.ac/institutes/grid.412920.c schema:Organization
    109 https://www.grid.ac/institutes/grid.413363.0 schema:Organization
    110 https://www.grid.ac/institutes/grid.413696.f schema:Organization
    111 https://www.grid.ac/institutes/grid.414836.c schema:Organization
    112 https://www.grid.ac/institutes/grid.415842.e schema:Organization
    113 https://www.grid.ac/institutes/grid.417812.9 schema:Organization
    114 https://www.grid.ac/institutes/grid.417829.1 schema:Organization
    115 https://www.grid.ac/institutes/grid.417988.b schema:Organization
    116 https://www.grid.ac/institutes/grid.418037.9 schema:Organization
    117 https://www.grid.ac/institutes/grid.418082.7 schema:Organization
    118 https://www.grid.ac/institutes/grid.418113.e schema:Organization
    119 https://www.grid.ac/institutes/grid.418116.b schema:Organization
    120 https://www.grid.ac/institutes/grid.418119.4 schema:Organization
    121 https://www.grid.ac/institutes/grid.418189.d schema:Organization
    122 https://www.grid.ac/institutes/grid.418191.4 schema:Organization
    123 https://www.grid.ac/institutes/grid.418443.e schema:Organization
    124 https://www.grid.ac/institutes/grid.418596.7 schema:Organization
    125 https://www.grid.ac/institutes/grid.418936.1 schema:Organization
    126 https://www.grid.ac/institutes/grid.419227.b schema:Organization
    127 https://www.grid.ac/institutes/grid.419945.4 schema:Organization
    128 https://www.grid.ac/institutes/grid.422301.6 schema:Organization
    129 https://www.grid.ac/institutes/grid.42505.36 schema:Organization
    130 https://www.grid.ac/institutes/grid.426108.9 schema:Organization
    131 https://www.grid.ac/institutes/grid.428696.7 schema:Organization
    132 https://www.grid.ac/institutes/grid.452334.7 schema:Organization
    133 https://www.grid.ac/institutes/grid.452351.4 schema:Organization
    134 https://www.grid.ac/institutes/grid.476192.f schema:Organization
    135 https://www.grid.ac/institutes/grid.476460.7 schema:Organization
    136 https://www.grid.ac/institutes/grid.476461.6 schema:Organization
    137 https://www.grid.ac/institutes/grid.476471.7 schema:Organization
    138 https://www.grid.ac/institutes/grid.477443.7 schema:Organization
    139 https://www.grid.ac/institutes/grid.482015.a schema:Organization
    140 https://www.grid.ac/institutes/grid.482598.a schema:Organization
    141 https://www.grid.ac/institutes/grid.48769.34 schema:Organization
    142 https://www.grid.ac/institutes/grid.491861.3 schema:Organization
    143 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    144 https://www.grid.ac/institutes/grid.5288.7 schema:Organization
    145 https://www.grid.ac/institutes/grid.5613.1 schema:Organization
    146 https://www.grid.ac/institutes/grid.5645.2 schema:Organization
    147 https://www.grid.ac/institutes/grid.65499.37 schema:Organization
    148 https://www.grid.ac/institutes/grid.6612.3 schema:Organization
    149 https://www.grid.ac/institutes/grid.7445.2 schema:Organization
    150 https://www.grid.ac/institutes/grid.7637.5 schema:Organization
    151 https://www.grid.ac/institutes/grid.7700.0 schema:Organization
    152 https://www.grid.ac/institutes/grid.9851.5 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...